4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-042305
Director sold 117,000 shares at an average $12.07 ($1,412,414)
From the SEC's structured data for this filing
Trades in this filing
Burrell Terry-Ann · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-12 | Sale : show line 1 in the form | −24,302 | $11.25 | $273,400 | 147,545 | D |
| 2023-07-12 | Sale : show line 2 in the form | −78,071 | $12.15 | $948,289 | 69,474 | D |
| 2023-07-12 | Sale : show line 3 in the form | −3,195 | $13.18 | $42,124 | 66,279 | D |
| 2023-07-12 | Sale : show line 4 in the form | −3,157 | $14.08 | $44,457 | 63,122 | D |
| 2023-07-13 | Sale : show line 5 in the form | −8,275 | $12.59 | $104,143 | 54,847 | D |
| Open-market sales · 117,000 sh · avg $12.07 · $1,412,414 | ||||||
Loading xslF345X04/doc4.xml…